头颈癌远处转移的相关因素分析
该单中心回顾性分析纳入1022例头颈癌患者,141例(13.8%)诊断远处转移,累及283个部位。1、2、5、10年实际远处控制率分别为88%、84%、80%、79%。与远处转移相关的因素包括分期分组、区域淋巴结阳性、结外延伸、局部区域残留病变及口咽鳞癌HPV阴性状态。
要点
- 头颈癌患者中13.8%发生远处转移,累及283个部位。
- 1、2、5、10年实际远处控制率分别为88%、84%、80%、79%。
- 分期分组、区域淋巴结阳性、结外延伸、局部区域残留病变及口咽鳞癌HPV阴性与远处转移相关。
核心结论
- 头颈癌远处转移预后差,相关因素与原发肿瘤特征有关。
研究设计与样本
- 单中心患者队列的回顾性分析,为期18年,共1022例患者。
主要发现
- 1022例患者中141例(13.8%)诊断远处转移,累及283个部位。
- 1、2、5、10年实际远处控制率分别为88%、84%、80%、79%。
- 与远处转移相关的因素包括分期分组、区域淋巴结阳性、结外延伸、局部区域残留病变及口咽鳞癌HPV阴性状态。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most trials in head and neck cancer emphasize locoregional control, as this is the main pattern of therapy failure. However, up to 15% of patients develop distant metastases. The purpose of this study was to present the investigated factors associated with distant metastasis in a single-center patient cohort. METHODS: A retrospective analysis of a single-center patient cohort over an 18-year period has been performed. We report on prevalence and incidence of distant metastasis, timing in relation to locoregional failure, Kaplan-Meier analysis for actuarial distant control rates, and univariate analysis taking into account histological, etiologic, surgical, site-dependent, stage-dependent characteristics, modality of primary therapy, and locoregional control. RESULTS: Of 1022 patients, 141 (13.8%) were diagnosed with distant metastases involving 283 sites. Actuarial rates of distant control were 88%, 84%, 80%, and 79% at 1, 2, 5, and 10 years, respectively. Factors associated with distant metastasis are stage grouping and regional node positivity, extranodal extension, locoregional residual disease, and human papillomavirus (HPV) negative status in oropharyngeal squamous cell carcinoma. CONCLUSION: Distant metastases in head and neck cancer led to dismal prognosis. Factors associated with distant metastasis are related to characteristics of the primary tumor. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1733-1743, 2017.
引用
- Duprez F, Berwouts D, De Neve W, et al. Distant metastases in head and neck cancer. Head Neck. 2017. PMID: 28650113. doi:10.1002/hed.24687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。